A retrospective single center real world study assessing the efficacy of Ixazomib in newly diagnosed patients of Multiple Myeloma who transitioned from Bortezomib to Ixazomib
Latest Information Update: 22 Jul 2020
At a glance
- Drugs Ixazomib (Primary) ; Cyclophosphamide; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association